<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02763241</url>
  </required_header>
  <id_info>
    <org_study_id>HE581519</org_study_id>
    <nct_id>NCT02763241</nct_id>
  </id_info>
  <brief_title>Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis</brief_title>
  <official_title>Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Farmaline Co.,Ltd., Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators proposed that the Cleanoze® is superior to the traditional nasal saline&#xD;
      irrigation in term of the ease of use which will resulting in a better quality of life of the&#xD;
      participants. This study will compared the efficacy, adverse reactions, complications and&#xD;
      ease of use of Cleanoze® comparing with normal saline solution&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder&#xD;
      when dissolved in 250 ml of water is closely resembles the content of a body fluid which&#xD;
      normally baths the outside of the cells of the body. This fluid is isotonic solution.&#xD;
&#xD;
      The nasal saline irrigation is the common procedure for upper respiratory tract infection&#xD;
      patients including chronic rhinitis. The physician usually order the normal saline with&#xD;
      appropriate medication e.g. anti-histamines, nasal steroids and anti-biotics to treat this&#xD;
      condition.&#xD;
&#xD;
      The investigators proposed that the Cleanoze® is superior to the traditional nasal saline&#xD;
      irrigation in term of the ease of use which will resulting in a better quality of life of the&#xD;
      participants. This study will compared the efficacy, adverse reactions, complications and&#xD;
      ease of use of Cleanoze® comparing with normal saline solution.&#xD;
&#xD;
      Study Population: Any patients with chronic rhinitis (e.g. allergic rhinitis, vasomotor&#xD;
      rhinitis) will be randomized to receive the study or control medication. The investigators&#xD;
      will include the children 5 years and above which able to doing the lavage under the parents&#xD;
      assistant or by them self.&#xD;
&#xD;
      Study Design: Phase III randomized controlled trial&#xD;
&#xD;
      Sample Size: Estimate from pilot study, the 71 patients per arm was estimated (142&#xD;
      participants totally).&#xD;
&#xD;
      Study Duration:&#xD;
&#xD;
        -  Duration of enrollment is 1 year.&#xD;
&#xD;
        -  The patients will be followed up to 1 months depend on the disease conditions.&#xD;
&#xD;
        -  The data analysis will take 3 additional months&#xD;
&#xD;
        -  The full report will complete after the data analysis within 3 months&#xD;
&#xD;
        -  The total of 1 year and 6 months period needed for this study.&#xD;
&#xD;
      Primary Objective: To compare the satisfaction of the patients using Cleanoze® versus&#xD;
      conventional device&#xD;
&#xD;
      Secondary Objective(s):&#xD;
&#xD;
        -  The adherence to Cleanoze® device&#xD;
&#xD;
        -  The durability of the Cleanoze® device&#xD;
&#xD;
        -  The patient symptom score (VAS)&#xD;
&#xD;
        -  The SNOT-22 questionaire for evaluating the quality of life of the patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction score</measure>
    <time_frame>1 month</time_frame>
    <description>This score will be evaluated at the end of 1 month using using the satisfaction questionaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The adherence to Cleanoze® devic</measure>
    <time_frame>1 month</time_frame>
    <description>The adherence will be evaluated by the diary that the investigator given to the participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The durability of the Cleanoze® device</measure>
    <time_frame>1 month</time_frame>
    <description>The durability will be evaluated by inspecting the device at the end of 1 month period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The symptoms score of the patients</measure>
    <time_frame>1 month</time_frame>
    <description>The symptoms score will be evaluated using the one-question VAS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Sino-Nasal Outcome Test-22 Questionnaire (SNOT-22) score</measure>
    <time_frame>1 month</time_frame>
    <description>The SNOT-22 score will be evaluated by using SNOT-22 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 month</time_frame>
    <description>The adverse events will be recorded in the case record form at follow-up time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Rhinitis</condition>
  <arm_group>
    <arm_group_label>Cleanoze®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.&#xD;
The patient will be instructed to use this isotonic solution for nasal irrigation daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Syringe irrigation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal irrigation using sterile 0.9% NaCl 250 ml by 20 ml syringe&#xD;
The patient will be instructed to use this isotonic solution for nasal irrigation daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cleanoze®</intervention_name>
    <description>Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.</description>
    <arm_group_label>Cleanoze®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline (Syringe irrigation)</intervention_name>
    <description>Nasal irrigation using 250 ml normal saline pushing into the nostril by 20 ml syringe</description>
    <arm_group_label>Syringe irrigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patients with chronic rhinitis conditions regardless of any cause (e.g. allergic,&#xD;
             irritant, infection)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute or chronic rhinosinusitis&#xD;
&#xD;
          -  Acute nasopharyngitis (common cold)&#xD;
&#xD;
          -  Patients with a tendency to aspirate such as cerebrovascular accident, cranio-facial&#xD;
             diseases.&#xD;
&#xD;
          -  Sinunasal, nasopharyngeal and skull base tumors&#xD;
&#xD;
          -  Age under 5 years old.&#xD;
&#xD;
          -  Cannot administer a saline irrigation under the assistant of a care giver.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patorn Piromchai, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Khon Kaen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Otolaryngology, Khonkaen University</name>
      <address>
        <city>Muang</city>
        <state>Khonkaen</state>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>April 29, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>August 7, 2018</last_update_submitted>
  <last_update_submitted_qc>August 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Patorn Piromchai</investigator_full_name>
    <investigator_title>Assistance Professor</investigator_title>
  </responsible_party>
  <keyword>rhinitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

